Evidence map›Paper›PMID 41940107›Full record

ArticleFrontiers in artificial intelligence2026

Radiomics-integrated machine learning framework for quantitative breast cancer diagnosis.

Kaavya Jayakrishnan, Nitish Katal

Abstract read
In one paragraph

Article in Frontiers in artificial intelligence, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Kaavya JayakrishnanSchool of Electronics Engineering, Vellore Institute of Technology, Chennai, Tamil Nadu, India.
Nitish KatalCenter for Cyber Physical Systems, Vellore Institute of Technology, Chennai, Tamil Nadu, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and objective: Breast cancer is one of the most common cancer types affecting women worldwide, and its early detection is crucial for effective treatment. The proposed study offers an automated pipeline that uses deep learning, radiomics, and machine learning to segment and classify breast tumors. The pipeline takes ultrasound scans as input, segments the tumor using UNet, and uses the predicted segment to compute the radiomic features, which are then given as input to the machine learning models for classification. Methods: In the first phase of the proposed study, the ultrasound scans and the ground truth masks in the BUSI dataset, obtained by the radiologist, are used to extract the radiomic features, followed by training the machine learning (ML) models. These results are used as benchmarks to evaluate the performance and efficacy of the proposed segmentation model. The use of radiomics bridges the gap between medical imaging and quantitative analysis. The features extracted by the proposed system are shape-based and therefore provide morphological information about tumor cells. In the second phase, an automated deep learning pipeline is proposed, in which the UNet is trained to effectively segment tumorous regions in ultrasound scans. Once the segmentation mask is obtained, it is used to compute radiomic features, and the ML algorithms are trained to classify the tumor as benign or malignant. Results: The proposed UNet-Radiomics-ML framework achieves performance when compared to the benchmark results obtained in the first phase. The proposed framework achieves a mean IoU of 0.94231 and a classification accuracy of 97.8% for the testing data. Conclusions: The results obtained from this study truly have the potential to positively impact the diagnosis of breast cancer. The use of automated models like UNet for segmentation, radiomics for feature extraction, and ML algorithms for classification will help reduce human intervention and narrow the diagnostic process, yielding quick results.

Indexed as

breast cancerconvolutional neural networksmachine learningradiomicssupport vector machineUNet

Identifiers

PMID41940107
PMCPMC13043643

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.